Latest filing published 10 Apr 2019 for NGM Biopharmaceuticals INC.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Mchenry T. Tichenor discloses dealings in 4 companies, chiefly Belo Corp, HFF, Inc. and NGM Biopharmaceuticals Inc. In total, 14 filings cover trades dated from 29 March 2007 to 8 April 2019.
On the market, this insider has only ever bought: 2 purchases, €48k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant and 4 option exercises.
On 10 April 2019 came the latest disclosure, a transaction in NGM Biopharmaceuticals Inc. The latest purchase dates back some time: it was published 5,524 days ago, on 9 September 2011. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations